Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / ADR
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
1,295,426
-
Shares change
-
+7,737
-
Total reported value, excl. options
-
$46,959,843
-
Value change
-
+$724,066
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$36.25
Significant Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q3 2023
10 filings reported holding GSK - GLAXOSMITHKLINE PLC - ADR as of Q3 2023.
GLAXOSMITHKLINE PLC - ADR (GSK) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,295,426 shares
.
Largest 10 shareholders include KAHN BROTHERS GROUP INC (1,282,289 shares), Columbia Asset Management (9,960 shares), PARADIGM ASSET MANAGEMENT CO LLC (1,800 shares), PARK CIRCLE Co (800 shares), BARTLETT & CO. WEALTH MANAGEMENT LLC (240 shares), Bartlett & Co. LLC (240 shares), Byrne Asset Management LLC (56 shares), Retirement Group, LLC (40 shares), HUNTINGTON NATIONAL BANK (1 shares), and NICOLET BANKSHARES INC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.